8 unknown, 4 completed, 2 suspended. 9 Phase 1, 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 4, Unknown 3, Suspended 2 |
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 1 | Unknown 1 |
Follow AnewPharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Absorption, Metabolism and Excretion of [14C]CM082 in Human [14]CM082 suspension - Advanced Solid Tumor | Phase 1 | Completed | AnewPharma | 4 | 2021-07-05 | 2022-11-14 |
| Bioequivalency Study of CM082 Tablet in Healthy Volunteers CM082 tablet (test product), CM082 tablet (reference product) - Advanced Malignant Solid Tumors | Phase 1 | Completed | AnewPharma | 96 | 2020-06-01 | 2021-11-26 |
| A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers CM082 with fed or fasting - Advanced Malignant Solid Tumors | Phase 1 | Completed | AnewPharma | 24 | 2019-12-19 | 2020-05-21 |
| CM082 in Patients With Myopic Choroidal Neovascularization (CNV) CM082 - Myopic Choroidal Neovascularisation | Phase 1 | Suspended | AnewPharma | 96 | 2019-12-18 | 2021-03-10 |
| CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC) CM082 plus JS001 - Small Cell Lung Cancer | Phase 2 | Unknown | AnewPharma | 30 | 2019-09-18 | 2020-07-09 |
| CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). CM082 plus JS001 - Non-small Cell Lung Cancer | Phase 2 | Unknown | AnewPharma | 20 | 2019-04-02 | 2020-07-09 |
| Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors CM082 - Advanced Malignant Solid Tumors | Phase 1 | Unknown | AnewPharma | 19 | 2019-02-26 | 2022-11-14 |
| Safety and Tolerability of Oral CM082 in Patients With wAMD CM082 - Age-Related Macular Degeneration | Phase 2 | Unknown | AnewPharma | 64 | 2018-11-22 | 2020-01-13 |
| Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. CM082 plus JS001 - Mucosal Melanoma | Phase 2 | Unknown | AnewPharma | 40 | 2018-07-31 | 2019-07-05 |
| Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer CM082 plus paclitaxel - Advanced Gastric Cancer | Phase 1 | Unknown | AnewPharma | 21 | 2018-03-15 | 2019-02-21 |
| CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma CM082 combined with everolimus, CM082, Everolimus - Renal Cell Cancer Metastatic | Phase 3 | Unknown | AnewPharma | 390 | 2016-12-16 | 2021-02-08 |
| Study of the Combination of CM082 With Everolimus in Patients With mRCC CM082, Everolimus - Renal Cell Carcinoma Recurrent | Phase 1 | Unknown | AnewPharma | 18 | 2015-09-01 | 2018-01-10 |
| Phase 1 Study of CM082 in Patients With wAMD CM082 tablet - Age-Related Macular Degeneration | Phase 1 | Suspended | AnewPharma | 56 | 2015-03-01 | 2020-01-13 |
| Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China CM082 Tablet - Advanced Cancer | Phase 1 | Completed | AnewPharma | 44 | 2013-05-01 | 2019-07-05 |
Macular Degeneration (2) · Carcinoma, Non-Small-Cell Lung (1) · Small Cell Lung Carcinoma (1)
vorolanib (13) · Everolimus (2) · toripalimab (2) · Paclitaxel (1)
China (14)
Jun Guo, M.D (2) · Aiping Zhou, MD (1) · Feng Shao, Ph D (1) · Jin Li, M.D (1) · Jin-Wan Wang, M.D. (1) · Jun Guo, MD (1) · Ming Zhang, MD (1) · Wei Liu, M.A (1) · Xinan Sheng, M.D (1) · Yin Shen (1) · Youxin Chen (1) · Yuankai Shi, MD (1) · Zhao Jun, M.D (1)